Hawryluk P. Kent
- SEC CIK
- 0001673991
In the past year, 2 open-market purchase filings worth $798.4K and 1 sale filing worth $17.9K.
Current role at each company
- MBX MBX Biosciences, Inc.President & CEOas of May 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $798.4K
- 2 filings
- Sold
- $17.9K
- 1 filing
- Net
- +$780.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hawryluk P. Kent as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 (view filing) | May 6 | 2 days | Hawryluk P. KentPresident & CEO | SSale | −607 | $29.54 | −$17.9K | −0.1%727.7K after | |
| Mar 16, 2026 (view filing) | Mar 13 | 3 days | Hawryluk P. KentPresident & CEO | PPurchase | +18.5K | $28.41 | +$525.6K | +4.0%486.8K after | |
| Oct 21, 2025 (view filing) | Oct 20 | 1 day | Hawryluk P. KentPresident & CEO | PPurchase | +20.0K | $13.64 | +$272.8K | +4.5%468.3K after | |
| Feb 5, 2025 (view filing) | Feb 4 | 1 day | Hawryluk P. KentPresident & CEO | PPurchase | +50.0K | $10.69 | +$534.5K | +12.6%448.3K after |